What does this T-shirt mean to you? Zani Prinsloo
Videos and Photos - 20 Oct 2017
The Journey of an MSF T-shirt
Videos and Photos - 20 Oct 2017
Patricia Mazuru
Patricia Mazuru, Project Coordinator in Nsanje, MalawiVideos and Photos - 20 Oct 2017
Malaria
Videos and Photos - 20 Oct 2017
What is going on in northeast Nigeria?
Heather Pagano, former MSF advocacy representative in Abuja, explains the conflict in Borno and the context in which MSF is running humanitarian operations in the area.Videos and Photos - 20 Oct 2017
How MSF Brought Down the Price of the Pneumonia Vaccine
In 2016, MSF's Access Campaign succeeded in getting pharmaceutical giants Pfizer and GlaxoSmithKline to significantly drop the price of the pneumonia vaccine for humanitarian organisations working in emergency settings.Videos and Photos - 19 Oct 2017
HIV/Aids
Videos and Photos - 18 Oct 2017
Malawi: Daily struggles of the most vulnerable
Malawi has one of the most successful, innovative HIV programmes in the region after being heavily affected by the HIV epidemic in the late 90s.Videos and Photos - 18 Oct 2017
Yemen
Patient and Staff Stories - 18 Oct 2017
The last remnants of the Yemen health system
In the emergency room of the Al Kuwait hospital, Yemen, dozens of staff continue to work, even though they haven’t received their salaries for a year.Patient and Staff Stories - 18 Oct 2017
Tuberculosis
Briefing Document - 13 Oct 2017
Drug-Resistant Tuberculosis Treatment & Access to Delamanid in South Africa
Delamanid is one of the first new medicines developed for DR-TB treatment in 50 years. The standard treatment duration is for the first six months of DR-TB treatment. The WHO issued interim guidelines on DLM use to treat MDR-TB in November 2014 and on its use in treating children and adolescents in 2016. Delamanid is also included in the 19th WHO Model List of Essential medicines.Briefing Document - 13 Oct 2017